4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethylpyrazol-1-yl)pyridin-2-amine;2-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethylpyrazol-1-yl)-4-N-[(2-methyltriazol-4-yl)methyl]pyridine-2,4-diamine;(2-methyltriazol-4-yl)methanamine
C40H53ClF4N16 — CID 162101605
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethylpyrazol-1-yl)pyridin-2-amine;2-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethylpyrazol-1-yl)-4-N-[(2-methyltriazol-4-yl)methyl]pyridine-2,4-diamine;(2-methyltriazol-4-yl)methanamine
4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethylpyrazol-1-yl)pyridin-2-amine;2-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethylpyrazol-1-yl)-4-N-[(2-methyltriazol-4-yl)methyl]pyridine-2,4-diamine;(2-methyltriazol-4-yl)methanamine (PubChem CID 162101605) has the molecular formula C40H53ClF4N16 and a molecular weight of 869.42 g/mol. Its IUPAC name is 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethylpyrazol-1-yl)pyridin-2-amine;2-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethylpyrazol-1-yl)-4-N-[(2-methyltriazol-4-yl)methyl]pyridine-2,4-diamine;(2-methyltriazol-4-yl)methanamine.
Molecular Properties
| Compound Name | 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethylpyrazol-1-yl)pyridin-2-amine;2-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethylpyrazol-1-yl)-4-N-[(2-methyltriazol-4-yl)methyl]pyridine-2,4-diamine;(2-methyltriazol-4-yl)methanamine |
|---|---|
| PubChem CID | 162101605 |
| Molecular Formula | C40H53ClF4N16 |
| Molecular Weight | 869.42 g/mol |
| Exact Mass | 868.43 |
| IUPAC Name | 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethylpyrazol-1-yl)pyridin-2-amine;2-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethylpyrazol-1-yl)-4-N-[(2-methyltriazol-4-yl)methyl]pyridine-2,4-diamine;(2-methyltriazol-4-yl)methanamine |
| SMILES | Cc1cc(C)n(-c2cc(Cl)cc(NC3CCC(F)(F)CC3)n2)n1.Cc1cc(C)n(-c2cc(NCc3cnn(C)n3)cc(NC3CCC(F)(F)CC3)n2)n1.Cn1ncc(CN)n1 |
| InChI | InChI=1S/C20H26F2N8.C16H19ClF2N4.C4H8N4/c1-13-8-14(2)30(27-13)19-10-16(23-11-17-12-24-29(3)28-17)9-18(26-19)25-15-4-6-20(21,22)7-5-15;1-10-7-11(2)23(22-10)15-9-12(17)8-14(21-15)20-13-3-5-16(18,19)6-4-13;1-8-6-3-4(2-5)7-8/h8-10,12,15H,4-7,11H2,1-3H3,(H2,23,25,26);7-9,13H,3-6H2,1-2H3,(H,20,21);3H,2,5H2,1H3 |
| InChIKey | ZEYPAEORVLVKIP-UHFFFAOYSA-N |
| XLogP | 7.42 |
| TPSA | 184.95 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 61 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 869.42 |
| LogP ≤ 5 | 7.42 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 16 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162101605 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.